Pharma Express - Search News

Top three insurers reaped $7.3 billion through their drug middlemen's markups, FTC says

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" prescription price hikes of 1,000% or more.

CNN on MSN · 1d

FTC finds middlemen inflate specialty generic drug prices by billions of dollars

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs between 2017 and 2022,

The Financial Times · 1d

FTC says pharmacy benefits managers marked-up generic drug prices for $7.3bn gain

Regulator’s report finds companies ‘hiked costs’ for a range of medicines, including cancer and HIV treatments

Business Insider · 1d

FTC says ‘Big 3 PBMs’ marked up generic drugs by thousands of percent

The Federal Trade Commission published a second interim staff report on the prescription drug middleman industry, which it says focuses on

The Financial Express13d

What’s in store for pharmaceutical sector in 2025?

The industry is set to make notable progress in cutting-edge areas such as CAR-T cell therapy, mRNA vaccines, and the ...

The Financial Times1y

Pharma logistics for the post-Covid era

distribution centres and dedicated vehicles for pharma. Executive officer at NIPPON EXPRESS HOLDINGS, INC. It was also working on a digital platform to ensure end-to-end visibility of conditions ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Trending now